Overview: Differential gene expression - How to find new analgesic targets

Current Opinion in Investigational Drugs

Volumn 2, Issue 3, 2001, Pages 396-398

  Befort, K ^a   Costigan, M ^a   Woolf, C J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; GABAPENTIN; LOCAL ANESTHETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; RIBONUCLEASE; RNA; TRICYCLIC ANTIDEPRESSANT AGENT; NARCOTIC AGENT; NEUROPEPTIDE; SENSORY NEURON SPECIFIC (SNS) SODIUM CHANNEL; SODIUM CHANNEL;

ANALGESIA; ANALGESIC ACTIVITY; BIOMEDICAL TECHNOLOGY ASSESSMENT; CELL CLONE; CHRONIC PAIN; DNA MICROARRAY; DRUG SCREENING; DRUG TARGETING; EXPERIMENTAL MODEL; FUNCTIONAL ASSESSMENT; GENE EXPRESSION; GENE FUNCTION; GENE SEQUENCE; GENE TARGETING; HUMAN; INFLAMMATION; KNOCKOUT GENE; NOCICEPTION; NONHUMAN; REVIEW; SENSORY NERVE CELL; SEQUENCE ANALYSIS; SIDE EFFECT; VALIDATION PROCESS; ANIMAL; DRUG EFFECT; EXPRESSED SEQUENCE TAG; GENE EXPRESSION REGULATION; GENE LIBRARY; GENETICS; METABOLISM; METHODOLOGY; PAIN; POLYMERASE CHAIN REACTION;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; EXPRESSED SEQUENCE TAGS; GENE EXPRESSION REGULATION; GENE LIBRARY; GENE TARGETING; HUMANS; NARCOTICS; NEURONS, AFFERENT; NEUROPEPTIDES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PAIN; POLYMERASE CHAIN REACTION; SODIUM CHANNELS;

EID: 0035057306     PISSN: 09678298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action
2. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene
3. Cyclooxygenases 1 and 2
4. From ionic currents to molecular mechanisms: The structure and function of voltage-gated sodium channels
5. Ion channels of nociception
6. Neuronal plasticity - Increasing the gain in pain
7. Pain genes?: Natural variation and transgenic mutants
8. Neuropathic pain: Aetiology, symptoms, mechanisms, and management
9. Implications of recent advances in the understanding of pain pathophysiology for the assessment of pain in patients
10. The pathophysiology of chronic pain - Increased sensitivity to low threshold Aβ-fibre inputs
11. Approaches to the study of altered gene expression in pain
12. Subtractive cloning: Past, present, and future
13. Peripheral nervous system-specific genes identified by subtractive cDNA cloning
14. A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons
15. Nomenclature of voltage-gated sodium channels
16. Diversity of expression of the sensory neuron specific TTX-resistant voltage-gated sodium ion channels SNS and SNS2
17. Regulation of expression of the sensory neuron-specific sodium channel SNS in inflammatory and neuropathic pain
18. Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro
19. The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways
20. Two sodium channels contribute to the TTX-R sodium current in primary sensory neurons
21. NaN, a novel voltage-gated Na channel, is expressed preferentially in peripheral sensory neurons and down-regulated after axotomy
22. A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain
23. Voltage-gated sodium channels as therapeutic targets